Testing effectiveness (Phase 2)Ended earlyNCT01194960
What this trial is testing
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Who this might be right for
Hormone Refractory Prostate Cancer
Oxford BioMedica 25
Showing 20 of 95 results